000 01671 a2200433 4500
005 20250515084904.0
264 0 _c20080115
008 200801s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.00391-07
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLouie, Arnold
245 0 0 _aIn vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cNov 2007
300 _a3988-4000 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBacterial Proteins
_xgenetics
650 0 4 _aBiological Transport
_xgenetics
650 0 4 _aCiprofloxacin
_xpharmacology
650 0 4 _aDNA, Bacterial
_xgenetics
650 0 4 _aDrug Resistance, Bacterial
_xgenetics
650 0 4 _aDrug Resistance, Multiple
_xgenetics
650 0 4 _aEthidium
_xmetabolism
650 0 4 _aFluoroquinolones
_xpharmacology
650 0 4 _aLevofloxacin
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMutation
650 0 4 _aOfloxacin
_xpharmacology
650 0 4 _aReserpine
_xpharmacology
650 0 4 _aStreptococcus pneumoniae
_xdrug effects
700 1 _aBrown, David L
700 1 _aLiu, Weiguo
700 1 _aKulawy, Robert W
700 1 _aDeziel, Mark R
700 1 _aDrusano, George L
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 51
_gno. 11
_gp. 3988-4000
856 4 0 _uhttps://doi.org/10.1128/AAC.00391-07
_zAvailable from publisher's website
999 _c17374004
_d17374004